SCHEMBL25187425

SCHEMBL25187425

Cc1cc(C)n(-c2nc(N)c(-c3ccc(F)c(Cl)c3)c(N)n2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNN3 Q9UGI6 2/20 0.56
▸ HTT P42858 2/20 0.46
▸ MAPT P10636 3/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ BCL6 P41182 1/20 0.41
▸ GABRP O00591 1/20 0.41
▸ GABRD O14764 1/20 0.41
▸ GABRA1 P14867 1/20 0.41
▸ GABRB1 P18505 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41
▸ GABRA5 P31644 1/20 0.41
▸ GABRA3 P34903 1/20 0.41
▸ GABRA2 P47869 1/20 0.41
▸ GABRB2 P47870 1/20 0.41
▸ GABRA4 P48169 1/20 0.41
▸ GABRE P78334 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30421417 1.00 KCNN3 (0.56) KCNN3HTTMAPTCYP1A2CYP3A4
SCHEMBL18912248 0.74 HTT (0.54) KCNN3HTTMAPTCYP1A2CYP2C9
SCHEMBL25725895 0.74 KCNN3 (0.81) KCNN3MAPTPOLBMAPK1SMN1; SMN2
SCHEMBL17055469 0.72 L3MBTL1 (0.56) KCNN3HTTMAPTBCL6POLB
SCHEMBL25193575 0.72 KCNN3 (1.00) KCNN3MAPTPOLBMAPK1SMN1; SMN2
SCHEMBL2554109 0.70 HTT (0.55) KCNN3HTTMAPTCYP1A2CYP3A4
SCHEMBL29091967 0.69 PTGS2 (0.51) —
SCHEMBL30421421 0.68 KCNN3 (0.44) KCNN3HTTMAPTBCL6NPC1
SCHEMBL30421533 0.68 KCNN3 (0.43) KCNN3HTTPOLBMAPK1SMN1; SMN2
SCHEMBL4138642 0.67 HTT (0.68) HTTMAPTCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159500-A1 SK CHANNEL POSITIVE ALLOSTERIC MODULATORS CHAPMAN UNIVERSITY 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159500-A1 SK CHANNEL POSITIVE ALLOSTERIC MODULATORS KCNN1, KCNN4, KCNN2 KCNN3 4/4885HTT 1211/4885MAPT 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback